Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...

Globus Medical (GMED), which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider.

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Globus Medical Inc. stock grades by Barron's. View GMED fundamental and sentiment analysis powered by MarketGrader.

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

Stay informed and make well-informed decisions with our Ratings Table. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device ...

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 ...

Morningstar brands and products Company Portfolio ...